Lawrence A. Hill, PharmD, RPh, MBA,

Dr. Hill received a BS and a doctorate in pharmacy, completed a residency in hospital pharmacy, and practiced as a clinical pharmacist specializing in ambulatory care, before transitioning into clinical research with the pharmaceutical industry in 1994. He started his career at Eli Lilly, and subsequently went on to lead clinical science and clinical development groups at Actavis Pharmaceuticals and Mallinckrodt Pharmaceuticals. In July 2018 he was appointed to be CEO of Gan & Lee Pharmaceuticals USA, a company specializing in bringing diabetic solutions to patients around the world.